Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis-Reference-Cited by-同舟云学术

Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis

Published:2019-01-18 Issue:1 Volume:14 Page:e0210988
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ma Tian-Tian^ORCID,Wong Ian C. K.,Man Kenneth K. C.,Chen Yang,Crake Thomas,Ozkor Muhiddin A.,Ding Ling-Qing,Wang Zi-Xuan,Zhang Lin,Wei Li

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients;BMJ,2002

2. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis;D Ettehad;Lancet,2016

3. Statins for Prevention of Cardiovascular Disease in Adults;R Chou;JAMA,2016

4. WHO. Secondary prevention of noncommunicable diseases in low- and middle-income countries through community-based and health service interventions: World Health Organization-Wellcome Trust meeting report, 1–3 August 2001. 2002; Available: http://www.who.int/iris/handle/10665/42567

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-surgical interventions for preventing contralateral tissue loss and amputation in dysvascular patients with a primary major lower limb amputation;Cochrane Database of Systematic Reviews;2024-08-28

2. Single-pill combination for treatment of hypertension: Just a matter of practicality or is there a real clinical benefit?;European Journal of Internal Medicine;2024-08

3. Prognostic impact of optimal lifestyle advice and medical therapy in patients with peripheral arterial disease;Vasa;2024-01

4. Sex disparities in guideline-recommended therapies and outcomes after ST-elevation myocardial infarction in a contemporary nationwide cohort of patients over an eight-year period;Atherosclerosis;2023-06

5. The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman;Pharmacy;2023-04-26